e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical issues in granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiac symptoms are a survival predictor in sarcoidosis
T. Mikolasch (Cambridge (Cambridgeshire), United Kingdom), H. Yung (Cambridge (Cambridgeshire), United Kingdom), M. Thillai (Cambridge (Cambridgeshire), United Kingdom)
Source:
Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Session:
Clinical issues in granulomatous lung diseases
Session type:
E-poster session
Number:
3011
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Mikolasch (Cambridge (Cambridgeshire), United Kingdom), H. Yung (Cambridge (Cambridgeshire), United Kingdom), M. Thillai (Cambridge (Cambridgeshire), United Kingdom). Cardiac symptoms are a survival predictor in sarcoidosis. 3011
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Pulmonary sarcoidosis
Related content which might interest you:
BNP can be an all-cause mortality predictor in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Evaluation of a new cardiac arrhythmias predictor in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Factors associated with poor prognostic outcome in acute exacerbation of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 1067-1072
Year: 2010
Validation of a prognostic score for pulmonary embolism short-term mortality
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009
Assessment of cardiac involvement in patients with sarcoidosis
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Survival and predictive factors of mortality in patients with bronchiectasis
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
Gender-dependent predictors for survival in patients with COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Evaluating the prognosis of cardiac and pulmonary patients
Source: School Course 2013 - Clinical exercise testing
Year: 2013
Evaluating the prognosis of cardiac and pulmonary patients
Source: Course 2015 - Clinical exercise testing
Year: 2015
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism
Source: Eur Respir J 2009; 34: 1357-1363
Year: 2009
Pulmonary hypertension as a predictor of survival in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 230s
Year: 2003
Prognostic predictors of course sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept